Rapid determination of rifaximin on dried blood spots by LC-ESI-MS

Biomedical Chromatography

Volumn 25, Issue 11, 2011, Pages 1201-1207

  Nageswara Rao, R ^a   Vali, R Mastan ^a   Ramachandra, Bondigalla ^a   Maurya, Pawan K ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Dried blood spots; High throughput; LC ESI MS; Monolithic column; Rifaximin

Indexed keywords

BLOOD; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT MONITORING; SILICA; SOLVENT EXTRACTION;

CLINICAL SETTINGS; DRIED BLOOD SPOT; HIGH-THROUGHPUT; LIQUID CHROMATOGRAPHY ELECTROSPRAY; LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION MASS SPECTROMETRIC; MONOLITHIC COLUMNS; RIFAXIMIN; SIMPLE++; SPECTROMETRIC METHODS; THERAPEUTIC DRUG MONITORING;

ELECTROSPRAY IONIZATION;

RIFAMPICIN; RIFAXIMIN; SILICON DIOXIDE; SOLVENT; RIFAMYCIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FLOW RATE; HIGH THROUGHPUT SCREENING; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; ANIMAL; BLOOD; CHEMISTRY; DRIED BLOOD SPOT TESTING; DRUG STABILITY; LIMIT OF DETECTION; PROCEDURES; REPRODUCIBILITY; STATISTICAL MODEL; WISTAR RAT;

ANIMALS; CHROMATOGRAPHY, LIQUID; DRIED BLOOD SPOT TESTING; DRUG STABILITY; LIMIT OF DETECTION; LINEAR MODELS; MALE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; RIFAMYCINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 80053610439     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1591     Document Type: Article

References (24)

1. AbuRuz S, Millership J and McElnay J. Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metformin. Journal of Chromatography B 2006; 832: 202-207.
2. Allanson AL, Cotton MM, Tettey JNA and Boyter AC. Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: a potential method for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 963-969.
3. Barfield M, Spooner N, Lad R, Parry S and Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. Journal of Chromatography B 2008; 870: 32-37.
4. Bergqvist Y, Doverskog M and Al Kabbani J. High-performance liquid chromatographic determination of (SR)- and (RS)-enantiomers of mefloquine in plasma and capillary blood sampled on paper after derivatization with (-)-1-(9-fluorenyl)ethyl chloroformate. Journal of Chromatography B 1994; 652: 73-81.
5. Chace D, Adam BW, Smith SJ, Alexander JR, Hillman SL and Hannon WH. Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays. Clinical Chemistry 1999; 45: 1269-1277.
6. Coombes EJ, Gamlen TR, Batstone GF and Holgate ST. The validation of a fluoroimmunoassay for the determination of theophylline concentration in dried blood spots suitable for domiciliary therapeutic drug monitoring. Clinica Chimica Acta 1984; 136: 187-195.
7. Descombe JJ, Dubourg D, Picard M and Palazzini E. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. International Journal of Clinical Pharmacology Research 1994; 14: 51-56.
8. Gionchetti P, Rizzello F, Venturi A, Ugolini F, Rossi M, Brigidi P, Johansson R, Ferrieri A, Poggioli G and Campieri M. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Alimentary Pharmacology and Therapeutics 1999; 13: 713-718.
9. Green MD, Mount DL and Nettey H. High-performance liquid chromatographic assay for the simultaneous determination of sulfadoxine and pyrimethamine from whole blood dried onto filter paper. Journal of Chromatography B 2002; 767: 159-162.
10. Guthrie R and Susi A. A simple phenylamine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32: 338.
11. Hoogtanders K, Van der HJ, Christiaans M, Edelbroek P, van Hooff JP and Stolk LML. Therapeutic drug monitoring of tacrolimus with the dried blood spot method. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 658-664.
12. Huang DB and Dupont HL. Rifaximin - a novel antimicrobial for enteric infections. Journal of Infection 2005; 50: 97-106.
13. ICH. Guideline Q2B, Text on Validation of Analytical Procedures. International Conference on Harmonization 1996; available from:.
14. Kolawole JA, Taylor RB and Moody RR. Determination of proguanil and metabolites in small sample volumes of whole blood stored on filter paper by high-performance liquid chromatography. Journal of Chromatography B 1995; 674: 149-154.
15. Lv J, Meng XJ, Wang FQ, Tang H and Liu ZM. Separation and determination of rifaximin and Quinone-rifaximin by HPLC. Chinese Journal of Pharmaceutical Analysis 2004; 24: 333-337.
16. Centers for Disease Control and Prevention. Quality Assurance and Proficiency Testing for Newborn Screening, 2006.
17. Rao RN, Shinde DD and Agawane SB. Rapid determination of rifaximin in rat serum and urine by direct injection on to a shielded hydrophobic stationary phase by HPLC. Biomedical Chromatography 2009a; 23: 563-567.
18. Rao RN, Vali RM and Shinde DD. On-line 2D-LC-ESI/MS/MS determination of Rifaximin in rat serum. Biomedical Chromatography 2009b; 23: 1145-1150.
19. Rao RN, Maurya PK, Ramesh M, Srinivas R and Agwane SB. Development of a validated high-throughput LC-ESI-MS method for determination of sirolimus on dried blood spots. Biomedical Chromatography 2010; 24: 1356-1364.
20. Vaira D, Menegatti M, Miglioli M, Ferrieri A, Holton J, Biasco G, Azzarone P, Ricci C, Gusmaroli R, Milesi F, Rodi M, Giorcelli W and Barbara L. Rifaximin suspension for the eradiction of Helicobacter pylori. Current Therapeutic Research 1997; 58: 300-308.
21. Venturini AP. Pharmacokinetics of L/105, a new rifamycin in rats and dogs, after oral administration. Chemotherapy 1983; 29: 1-3.
22. Venturini I, Ferrieri A, Farina F, Cosenza F, Avallone R, Corsi L, Baraldi M and Zeneroli ML. Evaluation of rifaximin, placebo and lactulose in reducing the levels of benzodiazepine-like compounds in patients with liver cirrhosis: a pilot study. Drugs Under Experimental and Clinical Research 2005; 31: 161-168.
23. Wang J, Wang JL and Bao H. RP-HPLC determination of rifaximin. Chinese Journal of New Drugs 2003; 12: 932-937.
24. Zhang X, Duan J, Li K, Zhou L and Zhai S. Sensitive quantification of rifaximin in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2007; 850: 348-355.